The Role of Mitochondrial Bioenergetics in Resilience in Older Adults With Gynecologic Cancer Receiving Cancer Reductive Treatment
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test, Other
Study Type: Observational
SUMMARY
The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 50
Healthy Volunteers: f
View:
• Ability to understand and willingness to sign an IRB-approved informed consent
• Age ≥50 years at the time of enrollment
• Newly diagnosed or suspected FIGO Stage II-IV ovarian/primary peritoneal/fallopian tube carcinoma of any histological subtype OR FIGO Stage II-IV endometrial carcinoma of any histological subtype
• Planned, standard of care treatment consisting of neoadjuvant chemotherapy, tumor reduction surgery, and adjuvant chemotherapy
• Ability to read and understand the English language
Locations
United States
North Carolina
Atrium Health Levine Cancer
RECRUITING
Charlotte
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITING
Winston-salem
Contact Information
Primary
Brandy Baker
brandy.baker@advocatehealth.org
(336) 713-8941
Time Frame
Start Date: 2025-11
Estimated Completion Date: 2027-04
Participants
Target number of participants: 30
Treatments
Advanced gynecological cancers
Participants 50 years and older with suspected or newly diagnosed advanced gynecological cancer (ovarian/primary peritoneal/fallopian tube or endometrial carcinoma of any histological subtype) who are planned to undergo SOC treatment.
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences